Evidence map›Paper›PMID 32668198›Full record

ArticleCell2020

The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.

Emma S Winkler, Swathi Shrihari, Barry L Hykes, Scott A Handley, Prabhakar S Andhey, Yan-Jang S Huang, Amanda Swain, Lindsay Droit, Kranthi K Chebrolu, Matthias Mack and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 1 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 1 synthesis or guideline pooled it, 202 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Frontiers in microbiology · 2026
    Article
  17. Review
  18. Review
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Emma S WinklerDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Swathi ShrihariDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Barry L HykesDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Scott A HandleyDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Prabhakar S AndheyDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Yan-Jang S HuangDepartment of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Biosecurity Research Institute, Kansas State University, Manhattan, KS 66506, USA.
Amanda SwainDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Lindsay DroitDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Kranthi K ChebroluProteomics and Mass Spectrometry Facility, Donald Danforth Plant Science Center, St. Louis, MO 63132, USA.
Matthias MackDepartment of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Dana L VanlandinghamDepartment of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Biosecurity Research Institute, Kansas State University, Manhattan, KS 66506, USA.
Larissa B ThackrayDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Marina CellaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Thaddeus S StappenbeckDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Michael S DiamondDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: diamond@wusm.wustl.edu.
Washington University in St. Louis · USKansas State University · USCleveland Clinic Lerner College of Medicine · USDonald Danforth Plant Science Center · USUniversity Hospital Regensburg · DE

Funding

TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI David W Piston · 2018 to 2026
$7.6M
Structure-Function Analysis of Mxra8 Interaction with Alphaviruses.R01AI143673 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, FREMONT, DAVED H. · 2019 to 2025
$6.5M
Chikungunya Virus Replication and PathogenesisR01AI123348 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DERMODY, TERENCE S., DIAMOND, MICHAEL S · 2016 to 2020
$3.7M
Gut Microbiota Modulation of Chikungunya Virus Infection and PathogenesisR01AI152484 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, FISCHBACH, MICHAEL ANDREW · 2021 to 2025
$3.2M
Impairment of B cell Responses by Pathogenic Chikungunya VirusesR01AI141436 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DIAMOND, MICHAEL S, MORRISON, THOMAS E · 2019 to 2023
$3.2M
IFN Dependent Control of Acute and Chronic Chikungunya Virus Induced DiseaseR01AI127513 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, LENSCHOW, DEBORAH J · 2017 to 2020
$2.1M
Regulation of Antiviral Responses in Plasmacytoid Dendritic Cells to Chikungunya Virus by the Gut MicrobiotaF30AI152327 · NIAID · WASHINGTON UNIVERSITY · PI WINKLER, EMMA SUENING · 2021 to 2022
$84k
NIAID NIH HHS F30 AI152327NIAID NIH HHS R01 AI123348NIAID NIH HHS R01 AI127513NIAID NIH HHS R01 AI141436NIAID NIH HHS R01 AI143673NIAID NIH HHS R01 AI152484NIAID NIH HHS T32 AI007163NIAMS NIH HHS P30 AR073752
6 · The paper itself

Abstract

Chikungunya virus (CHIKV), an emerging alphavirus, has infected millions of people. However, the factors modulating disease outcome remain poorly understood. Here, we show in germ-free mice or in oral antibiotic-treated conventionally housed mice with depleted intestinal microbiomes that greater CHIKV infection and spread occurs within 1 day of virus inoculation. Alteration of the microbiome alters TLR7-MyD88 signaling in plasmacytoid dendritic cells (pDCs) and blunts systemic production of type I interferon (IFN). Consequently, circulating monocytes express fewer IFN-stimulated genes and become permissive for CHIKV infection. Reconstitution with a single bacterial species, Clostridium scindens, or its derived metabolite, the secondary bile acid deoxycholic acid, can restore pDC- and MyD88-dependent type I IFN responses to restrict systemic CHIKV infection and transmission back to vector mosquitoes. Thus, symbiotic intestinal bacteria modulate antiviral immunity and levels of circulating alphaviruses within hours of infection through a bile acid-pDC-IFN signaling axis, which affects viremia, dissemination, and potentially transmission.

Indexed as

Gastrointestinal MicrobiomeAnimalsAnti-Bacterial AgentsBile Acids and SaltsChikungunya FeverChikungunya virusDendritic CellsEubacterialesFecal Microbiota TransplantationInterferon Type IMaleMembrane GlycoproteinsMiceMice, Inbred C57BLMice, KnockoutMonocytesAnti-Bacterial AgentsBile Acids and SaltsInterferon Type IMembrane GlycoproteinsMyd88 protein, mouseMyeloid Differentiation Factor 88RNA, ViralStat1 protein, mouseSTAT1 Transcription FactorTlr7 protein, mouseToll-Like Receptor 7alphavirusbile acidchikungunyaClostridiuminterferonmicrobiomemonocytepathogenesisplasmacytoid dendritic cell

Identifiers

PMID32668198
PMCPMC7483520
OpenAlexW3043244612

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.